| Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages P Ghasemiyeh, S Mohammadi-Samani Research in pharmaceutical sciences 13 (4), 288-303, 2018 | 600 | 2018 |
| Potential of nanoparticles as permeation enhancers and targeted delivery options for skin: Advantages and disadvantages P Ghasemiyeh, S Mohammadi-Samani Drug design, development and therapy, 3271-3289, 2020 | 186 | 2020 |
| Hydrogels as drug delivery systems; pros and cons P Ghasemiyeh, S Mohammadi-Samani Trends in pharmaceutical sciences 5 (1), 7-24, 2019 | 180 | 2019 |
| A focused review on technologies, mechanisms, safety, and efficacy of available COVID-19 vaccines P Ghasemiyeh, S Mohammadi-Samani, N Firouzabadi, A Dehshahri, ... International immunopharmacology 100, 108162, 2021 | 110 | 2021 |
| Major neurologic adverse drug reactions, potential drug–drug interactions and pharmacokinetic aspects of drugs used in COVID-19 patients with stroke: a narrative review P Ghasemiyeh, A Borhani-Haghighi, I Karimzadeh, ... Therapeutics and clinical risk management, 595-605, 2020 | 60 | 2020 |
| Cyproterone acetate-loaded nanostructured lipid carriers: effect of particle size on skin penetration and follicular targeting P Ghasemiyeh, A Azadi, S Daneshamouz, R Heidari, N Azarpira, ... Pharmaceutical development and technology 24 (7), 812-823, 2019 | 56 | 2019 |
| Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2 N Firouzabadi, P Ghasemiyeh, F Moradishooli, S Mohammadi-Samani International Immunopharmacology 117, 109968, 2023 | 38 | 2023 |
| Polymers blending as release modulating tool in drug delivery P Ghasemiyeh, S Mohammadi-Samani Frontiers in materials 8, 752813, 2021 | 30 | 2021 |
| Ethosomes as dermal/transdermal drug delivery systems: applications, preparation and characterization A Jafari, S Daneshamouz, P Ghasemiyeh, S Mohammadi-Samani Journal of Liposome Research 33 (1), 34-52, 2023 | 26 | 2023 |
| COVID-19 outbreak: Challenges in pharmacotherapy based on pharmacokinetic and pharmacodynamic aspects of drug therapy in patients with moderate to severe infection P Ghasemiyeh, S Mohammadi-Samani Heart & Lung 49 (6), 763-773, 2020 | 23 | 2020 |
| Drug-based therapeutic strategies for COVID-19-infected patients and their challenges K Zarkesh, E Entezar-Almahdi, P Ghasemiyeh, M Akbarian, M Bahmani, ... Future microbiology 16 (18), 1415-1451, 2021 | 18 | 2021 |
| Cyproterone acetate-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs): preparation and optimization P Ghasemiyeh, A Azadi, S Daneshamouz, S Mohammadi Samani Trends in pharmaceutical sciences 3 (4), 275-286, 2017 | 18 | 2017 |
| Iron chelating agents: promising supportive therapies in severe cases of COVID-19? P Ghasemiyeh, S Mohammadi-Samani Trends in Pharmaceutical Sciences 6 (2), 65-66, 2020 | 13 | 2020 |
| A simple and validated HPLC method for vancomycin assay in plasma samples: the necessity of TDM center development in Southern Iran P Ghasemiyeh, A Vazin, F Zand, A Azadi, I Karimzadeh, ... Research in Pharmaceutical Sciences 15 (6), 529-540, 2020 | 12 | 2020 |
| The effect of size, morphology and surface properties of mesoporous silica nanoparticles on pharmacokinetic aspects and potential toxicity concerns U Niroumand, N Firouzabadi, G Goshtasbi, B Hassani, P Ghasemiyeh, ... Frontiers in Materials 10, 1189463, 2023 | 11 | 2023 |
| Novel topical drug delivery systems in acne management: Molecular mechanisms and role of targeted delivery systems for better therapeutic outcomes P Ghasemiyeh, S Mohammadi-Samani, K Noorizadeh, O Zadmehr, ... Journal of Drug Delivery Science and Technology 74, 103595, 2022 | 10 | 2022 |
| Psychiatric adverse drug reactions and potential anti-COVID-19 drug interactions with psychotropic medications P Ghasemiyeh, N Mortazavi, I Karimzadeh, A Vazin, L Mahmoudi, ... Iranian Journal of Pharmaceutical Research: IJPR 20 (3), 66, 2021 | 9 | 2021 |
| The necessity of early anti-inflammatory therapy initiation in cases with mild-to-moderate COVID-19: A personal experience from an attending pharmacist and his resident P Ghasemiyeh, S Mohammadi-Samani Authorea Preprints, 2024 | 8 | 2024 |
| The role of different factors in pathophysiology of acne and potential therapeutic options: A brief review P Ghasemiyeh, K Noorizadeh, D Dehghan, S Rasekh, O Zadmehr, ... Trends in Pharmaceutical Sciences 8 (2), 107-118, 2022 | 5 | 2022 |
| Oxybutynin-nanoemulgel formulation as a successful skin permeation strategy: in-vitro and ex-vivo evaluation S Mohammadi-Samani, P Masoumzadeh, P Ghasemiyeh, S Alipour Frontiers in Materials 9, 848629, 2022 | 5 | 2022 |
Soliman Mohammadi SamaniProfessor of Pharmaceutics, School of pharmacy, Shiraz University of Medical Sciences, Shiraz, IranE-mail confirmado em sums.ac.ir
